Pipeline
Novel immunotherapies for areas of high unmet need
Centauri has developed a pipeline of novel immunotherapeutic molecules based on our proprietary Alphamer® platform. Our current focus is on addressing the urgent need for novel infectious disease treatments. We also have strong proof-of-concept data for the application of Alphamers in oncology.